ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,112, issued on Jan. 28, was assigned to Southern Research Institute (Birmingham, Ala.) and Pinotbio Inc. (Gyeonggi-Do, South Korea).
"Composition for treating blood cancer using 4'-thio-5-Aza-2'-deoxycytidine and uses thereof" was invented by Mark J. Suto (Homewood, Ala.), Rebecca Boohaker (Birmingham, Ala.), Doo Young Jung (Daejeon, South Korea), Jin Soo Lee (Gyeonggi-do, South Korea) and Hyunyong Cho (Gyeonggi-do, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pharmaceutical compositions for treating blood cancer, which includes 4'-thio-5-aza-2'-deoxycytidine (Aza-T-dCyd), and methods of treating blood ...